Vanguard Fiduciary Trust
LUNG icon

Vanguard Fiduciary Trust’s Pulmonx LUNG Stock Holding History

Vanguard Fiduciary Trust’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$326K Sell
250,511
-30,737
-11% -$42.3K ﹤0.01% 3421
2026
Q1 		$363K Buy
+281,248
New +$465K ﹤0.01% 3316

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Vanguard Fiduciary Trust's LUNG Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Pulmonx (LUNG) stake by 11% in Q2 2026, selling an estimated $42.3K and leaving 250,511 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #3421.

Vanguard Fiduciary Trust first reported a position in LUNG in Q1 2026 and has held it in 2 quarters since. The position peaked at $363K in Q1 2026. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Vanguard Fiduciary Trust held 250,511 shares of Pulmonx worth $326K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 30,737 Pulmonx shares in Q2 2026, an estimated $42.3K.
  • Pulmonx made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3421 holding.
  • Vanguard Fiduciary Trust first reported a position in Pulmonx in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Pulmonx position peaked at $363K in Q1 2026.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.